These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4201115)

  • 1. Demonstration of the production of the long acting thyroid stimulator (LATS) by peripheral lymphocytes cultured in vitro.
    Wall JR; Good BF; Forbes IJ; Hetzel BS
    Clin Exp Immunol; 1973 Aug; 14(4):555-61. PubMed ID: 4201115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graves--Basedow disease and immunity.
    Thomas M; Perrault M
    Mater Med Pol; 1975; 7(1):31-4. PubMed ID: 1079897
    [No Abstract]   [Full Text] [Related]  

  • 3. [An antibody called LATS].
    Letonturier P; Tourneur R
    Nouv Presse Med; 1975 Jan; 4(3):177-9. PubMed ID: 1079340
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.
    Földes J; Takó J; Bános C; Gesztesi E
    Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
    Romaldini JH; Pinchera A; Fenzi GF; Grasso L; Raccis E; Mariotti S; Baschieri L
    Folia Endocrinol; 1974 Feb; 27(1):110-6. PubMed ID: 4549507
    [No Abstract]   [Full Text] [Related]  

  • 6. LATS production by lymphocyte culture in patients with Graves' disease.
    Miyai K; Fukuchi M; Kumahara Y; Abe H
    J Clin Endocrinol Metab; 1967 Jun; 27(6):855-60. PubMed ID: 4165125
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
    Chopra IJ; Solomon DH; Limberg NP
    J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
    Knight A; Adams DD
    Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of immunologic reaction of long acting thyroid stimulator (LATS) to thyroid components, and the demonstration of a plasma inhibitor LATS.
    Burke G
    J Lab Clin Med; 1967 May; 69(5):713-27. PubMed ID: 4960804
    [No Abstract]   [Full Text] [Related]  

  • 10. [LATS and other antibodies against the TSH receptor].
    Rodríguez Zapata MM
    Med Clin (Barc); 1983 Feb; 80(4):177-81. PubMed ID: 6134881
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of the production of human thyroid-stimulating immunoglobulins (HTSI) by Graves' lymphocytes cultured in vitro with phytohaemagglutinin (PHA).
    Knox AJ; von Westarp C; Row VV; Volpé R
    Metabolism; 1976 Nov; 25(11):1217-23. PubMed ID: 185485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absent biological demonstration of "long-acting thyroid stimulator" (LATS) in endemic euthyroid iodine deficiency goiters].
    Stelzer M; Mertz DP
    Munch Med Wochenschr; 1969 Jun; 111(23):1306-9. PubMed ID: 5820134
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent findings on TSH, LATS and TSI].
    Yamashita K; Kugai N
    Nihon Rinsho; 1981 Sep; 39(9):2949-53. PubMed ID: 6121923
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoelectric focusing of long-acting thyroid stimulator immunoglobulin G.
    Lonergan C; Babiarz D; Burke G
    J Clin Endocrinol Metab; 1973 Mar; 36(3):439-44. PubMed ID: 4631063
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R; Letonturier P; Sénécal P
    Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
    [No Abstract]   [Full Text] [Related]  

  • 16. [Standardization of the radiobiological method for determination of long-acting thyroid stimulator (LATS) in human serum].
    Muramoto E; Nicolau W; Ikeda E; de Assis LM; Pieroni RR
    AMB Rev Assoc Med Bras; 1972 Oct; 18(10):379-88. PubMed ID: 4539360
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relation between Basedow's disease and Hashimoto thyroiditis].
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Endokrinologie; 1971 Apr; 57(3):329-37. PubMed ID: 5108742
    [No Abstract]   [Full Text] [Related]  

  • 18. Concentration of long-acting thyroid stimulator (LATS) by subfractionation of gamma G globulin from Graves' disease serum.
    Miyai K; Werner SC
    J Clin Endocrinol Metab; 1966 May; 26(5):504-12. PubMed ID: 5952570
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 20. LATS and Graves' disease.
    Soloman DH; Chopra IJ
    Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.